575 related articles for article (PubMed ID: 23731741)
1. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
Smith A; Cubillo A; Barrett N; Giampietro V; Simmons A; Brammer M; Rubia K
Biol Psychiatry; 2013 Oct; 74(8):615-22. PubMed ID: 23731741
[TBL] [Abstract][Full Text] [Related]
2. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
Psychol Med; 2014 Feb; 44(3):633-46. PubMed ID: 23597077
[TBL] [Abstract][Full Text] [Related]
3. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.
Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer MJ; Simmons A; Rubia K
Cereb Cortex; 2014 Jan; 24(1):174-85. PubMed ID: 23048018
[TBL] [Abstract][Full Text] [Related]
4. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.
Kowalczyk OS; Cubillo AI; Smith A; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
Eur Neuropsychopharmacol; 2019 Oct; 29(10):1102-1116. PubMed ID: 31358436
[TBL] [Abstract][Full Text] [Related]
6. Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD.
Kowalczyk OS; Cubillo AI; Criaud M; Giampietro V; O'Daly OG; Mehta MA; Rubia K
Psychopharmacology (Berl); 2023 Oct; 240(10):2045-2060. PubMed ID: 37500785
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
Rubia K; Halari R; Mohammad AM; Taylor E; Brammer M
Biol Psychiatry; 2011 Aug; 70(3):255-62. PubMed ID: 21664605
[TBL] [Abstract][Full Text] [Related]
8. Shared and disorder-specific prefrontal abnormalities in boys with pure attention-deficit/hyperactivity disorder compared to boys with pure CD during interference inhibition and attention allocation.
Rubia K; Halari R; Smith AB; Mohammad M; Scott S; Brammer MJ
J Child Psychol Psychiatry; 2009 Jun; 50(6):669-78. PubMed ID: 19236528
[TBL] [Abstract][Full Text] [Related]
9. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K
JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorder.
Rubia K; Halari R; Cubillo A; Smith AB; Mohammad AM; Brammer M; Taylor E
Neuropsychopharmacology; 2011 Jul; 36(8):1575-86. PubMed ID: 21451498
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex.
Gilbert DL; Ridel KR; Sallee FR; Zhang J; Lipps TD; Wassermann EM
Neuropsychopharmacology; 2006 Feb; 31(2):442-9. PubMed ID: 16034446
[TBL] [Abstract][Full Text] [Related]
14. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
Husarova V; Bittsansky M; Ondrejka I; Dobrota D
Psychiatry Res; 2014 Apr; 222(1-2):75-83. PubMed ID: 24679996
[TBL] [Abstract][Full Text] [Related]
15. Attention-deficit/hyperactivity disorder in childhood epilepsy: a neuropsychological and functional imaging study.
Bechtel N; Kobel M; Penner IK; Specht K; Klarhöfer M; Scheffler K; Opwis K; Schmitt-Mechelke T; Capone A; Weber P
Epilepsia; 2012 Feb; 53(2):325-33. PubMed ID: 22242637
[TBL] [Abstract][Full Text] [Related]
16. Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response.
Sangal RB; Sangal JM
Clin Neurophysiol; 2006 Sep; 117(9):1996-2006. PubMed ID: 16890481
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of methylphenidate and atomoxetine on intrinsic brain activity in children with attention deficit hyperactivity disorder.
Shang CY; Yan CG; Lin HY; Tseng WY; Castellanos FX; Gau SS
Psychol Med; 2016 Nov; 46(15):3173-3185. PubMed ID: 27574878
[TBL] [Abstract][Full Text] [Related]
18. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
Wang Y; Zheng Y; Du Y; Song DH; Shin YJ; Cho SC; Kim BN; Ahn DH; Marquez-Caraveo ME; Gao H; Williams DW; Levine LR
Aust N Z J Psychiatry; 2007 Mar; 41(3):222-30. PubMed ID: 17464703
[TBL] [Abstract][Full Text] [Related]
19. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
20. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
